Advancing women’s health through laboratory diagnostics
The dialogue aims to showcase cutting-edge innovations, address key challenges and uncover collaboration opportunities that will enhance diagnostic capabilities for addressing women specific health needs.
📅Date & Time: 3 February 2025 | 11:00 - 16:00
📍Location: Hall 1 Room 6
Headline sponsor
Associate sponsors
Objectives
- Analyse the role of diagnostic tools in early detection, prevention and treatment of women specific conditions such as breast cancer, PCOS and reproductive health
- Discuss personalised medicine and how tailored diagnostics can transform hormonal and chronic disease management in women
- Explore how partnerships between labs and the pharmaceutical sector can accelerate advancements in women’s healthcare diagnostics.
Who shall attend?
- Laboratory Director/Head of Laboratory
- Pathologist
- Diagnostic Company Representatives, Testing providers
- Medical Technologist
- Pharmaceutical Executives specialising in women’s health
Programme
The Impact of diagnostic innovation on women’s health:
Discussion will focus on how early detection through advanced diagnostics can improve management of conditions like reproductive health disorders, cancers and hormonal imbalances.
Personalised medicine and tailored diagnostics for women:
This session will explore breakthroughs in personalized diagnostics and their transformative impact onindividualized treatment plans for women.
